|
Safety and Efficacy Study of NUV-868 Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
NCT ID : 05252390
Protocol Number : NUV-868-01
Phase : 1/2
Location : Santa Monica, Ca
|
Mitchell Gross, M.D.
|
|
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder (SunRISe-2)
NCT ID : 04658862
Protocol Number : 17000139BLC3001 (Sunshine 2)
Phase : 3
Location : Saint John's Cancer Institute
|
Przemyslaw Twardowski, M.D.
|
|
A Study of ARV-766 Given by Mouth in Men With Metastatic Castration-resistant Prostate Cancer Who Have Progressed on Prior Approved Systemic Therapies
NCT ID : 05067140
Protocol Number : ARV-766mCRPC-101
Phase : 1/2
Location : Saint John's Cancer Institute
|
Przemyslaw Twardowski, M.D.
|
|
Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer
NCT ID : 03972657
Protocol Number : R5678-ONC-1879
Phase : 1/2
Location : Saint John's Cancer Institute
|
Przemyslaw Twardowski, M.D.
|
|
Metastatic Castration-Resistant Prostate Cancer (CAPItello-280)
NCT ID : 05348577
Protocol Number : D361EC00001 (CAPItello-280)
Phase : 3
Location : Santa Monica, Ca
|
Przemyslaw Twardowski, M.D.
|
|
White Button Mushroom Supplement for Biochemically Recurrent Prostate Cancer Following Local Therapy and in Therapy Naïve Patients
NCT ID : 04519879
Protocol Number : White Button Mushroom
Phase : 2
Location : Santa Monica, CA
|
Przemyslaw Twardowski, M.D.
|
